<--- Back to Details
First PageDocument Content
Blood / Coagulation system / Anatomy / CSL Behring / Von Willebrand disease / Factor VIII / Coagulation / CSL Limited / Hereditary angioedema / Haemophilia / Factor IX / Factor VII
Date: 2013-11-18 05:52:30
Blood
Coagulation system
Anatomy
CSL Behring
Von Willebrand disease
Factor VIII
Coagulation
CSL Limited
Hereditary angioedema
Haemophilia
Factor IX
Factor VII

News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

Add to Reading List

Source URL: www.cslbehring.at

Download Document from Source Website

File Size: 82,62 KB

Share Document on Facebook

Similar Documents

[Product Monograph Template - Schedule D]

[Product Monograph Template - Schedule D]

DocID: 1qWQL - View Document

News Releases  Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

DocID: 1qHpD - View Document

Microsoft Word - CINRYZE.Product Monographdoc

Microsoft Word - CINRYZE.Product Monographdoc

DocID: 1qE2h - View Document

Microsoft Word - FIRAZYR.Product Monographdoc

Microsoft Word - FIRAZYR.Product Monographdoc

DocID: 1qA9x - View Document

Fact Sheet CSL BehringCSL Sales $5.5 Billion CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we develop

Fact Sheet CSL BehringCSL Sales $5.5 Billion CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we develop

DocID: 1pVHk - View Document